Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome.
Mabrey FL, Gardner KM, Shannon Dorcy K, Perdue A, Smith HA, Davis AM, Hammer C, Rizzuto D, Jones S, Quach K, Scott BL, Hendrie PC, Percival MM, Walter RB, Appelbaum FR, Estey EH, Becker PS. Mabrey FL, et al. Among authors: shannon dorcy k. Blood Adv. 2020 Feb 25;4(4):611-616. doi: 10.1182/bloodadvances.2019000707. Blood Adv. 2020. PMID: 32074276 Free PMC article.
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome.
Shadman M, Mawad R, Dean C, Chen TL, Shannon-Dorcy K, Sandhu V, Hendrie PC, Scott BL, Walter RB, Becker PS, Pagel JM, Estey EH. Shadman M, et al. Among authors: shannon dorcy k. Am J Hematol. 2015 Jun;90(6):483-6. doi: 10.1002/ajh.23981. Epub 2015 Feb 27. Am J Hematol. 2015. PMID: 25689471 Free PMC article. Clinical Trial.
Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL, Deeg HJ, Becker PS, Hendrie PC, Walter RB, Ostronoff F, Appelbaum FR, Estey EH. Lionberger JM, et al. Among authors: shannon dorcy k. Br J Haematol. 2014 Aug;166(3):375-81. doi: 10.1111/bjh.12905. Epub 2014 Apr 18. Br J Haematol. 2014. PMID: 24749757 Free PMC article. Clinical Trial.
Value of routine 'day 14' marrow exam in newly diagnosed AML.
Yezefski T, Xie H, Walter R, Pagel J, Becker PS, Hendrie P, Sandhu V, Shannon-Dorcy K, Abkowitz J, Appelbaum FR, Estey E. Yezefski T, et al. Among authors: shannon dorcy k. Leukemia. 2015 Jan;29(1):247-9. doi: 10.1038/leu.2014.268. Epub 2014 Sep 10. Leukemia. 2015. PMID: 25204570 No abstract available.
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
Demirer T, Petersen FB, Appelbaum FR, Barnett TA, Sanders J, Deeg HJ, Storb R, Doney K, Bensinger WI, Shannon-Dorcy K, et al. Demirer T, et al. Among authors: shannon dorcy k. Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):1103-9. doi: 10.1016/0360-3016(95)00115-f. Int J Radiat Oncol Biol Phys. 1995. PMID: 7607931 Clinical Trial.
23 results